Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-18 Sale |
2025-02-20 7:38 pm |
Disc Medicine Inc. | IRON | Stephenson Pamela Chief Commercial Officer |
3,137 | $54.58 | $171,217 | 69,529 (Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:30 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
115 | $0.3481 | $40 | 147,514 (Direct) |
View |
2023-01-23 Sale |
2023-01-23 5:12 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
102 | $43.8 | $4,468 | 42,755 (Direct) |
View |
2023-01-19 Sale |
2023-01-20 4:05 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
1,774 | $43.9 | $77,886 | 42,857 (Direct) |
View |
2022-12-27 Sale(A) |
2023-01-09 6:42 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
469 | $19.06 | $8,940 | 44,631 (Direct) |
View |
2022-07-22 Sale(A) |
2023-01-09 6:41 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
106 | $24.67 | $2,615 | 45,649 (Direct) |
View |
2022-12-27 Sale |
2022-12-27 4:05 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
469 | $19.06 | $8,940 | 45,178 (Direct) |
View |
2022-10-24 Sale |
2022-10-25 4:00 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
104 | $19.58 | $2,036 | 45,647 (Direct) |
View |
2022-09-26 Sale |
2022-09-27 4:01 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
445 | $19.4 | $8,635 | 45,751 (Direct) |
View |
2022-07-22 Sale |
2022-07-25 4:14 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
106 | $24.67 | $2,615 | 46,196 (Direct) |
View |
2022-06-27 Sale |
2022-06-28 4:02 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
461 | $19.47 | $8,976 | 45,755 (Direct) |
View |
2022-06-14 Sale |
2022-06-16 9:51 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
40 | $1.01 | $40 | 62,732 (Direct) |
View |
2022-04-22 Sale |
2022-04-25 4:40 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
103 | $32.92 | $3,391 | 46,216 (Direct) |
View |
2022-03-28 Sale |
2022-03-29 4:00 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
454 | $30.52 | $13,858 | 46,319 (Direct) |
View |
2022-01-24 Sale |
2022-01-25 4:38 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
416 | $24.88 | $10,351 | 46,773 (Direct) |
View |
2021-12-27 Sale |
2021-12-27 4:02 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
474 | $23.92 | $11,339 | 25,589 (Direct) |
View |
2021-09-27 Sale |
2021-09-28 4:32 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
451 | $32.05 | $14,456 | 26,063 (Direct) |
View |
2021-06-25 Sale |
2021-06-28 4:02 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
471 | $36.01 | $16,961 | 26,514 (Direct) |
View |
2021-03-29 Sale |
2021-03-31 7:21 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
422 | $34.02 | $14,355 | 26,985 (Direct) |
View |
2020-12-28 Sale |
2020-12-29 4:19 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
460 | $39.07 | $17,974 | 21,907 (Direct) |
View |
2020-09-25 Sale |
2020-09-25 5:05 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
451 | $33.2 | $14,973 | 22,367 (Direct) |
View |
2020-06-25 Sale |
2020-06-26 5:02 pm |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
397 | $30.79 | $12,224 | 22,818 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-10 Option Award |
2025-02-12 6:48 pm |
N/A 2035-02-09 |
Disc Medicine Inc. | IRON | Stephenson Pamela Chief Commercial Officer |
36,000 | $0 | 108,666 (Direct) |
View |
2024-02-26 Option Award |
2024-02-27 5:38 pm |
N/A 2034-02-25 |
Disc Medicine Inc. | IRON | Stephenson Pamela Chief Commercial Officer |
91,666 | $0 | 91,666 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:12 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
75,778 | $0 | 0 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:30 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
119,560 | $0 | 147,514 (Direct) |
View |
2023-03-02 Equity Swap |
2023-03-02 4:54 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
22,242 | $0 | 0 (Direct) |
View |
2023-01-19 Option Award(A) |
2023-01-27 5:23 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
55,000 | $0 | 97,755 (Direct) |
View |
2023-01-19 Option Award |
2023-01-25 8:07 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
55,000 | $0 | 97,755 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 9:51 pm |
N/A 2032-06-14 |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
57,772 | $0 | 62,732 (Direct) |
View |
2022-01-18 Option Award |
2022-01-20 4:49 pm |
N/A N/A |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
21,600 | $0 | 47,189 (Direct) |
View |
2021-08-03 Option Award |
2021-08-05 5:29 pm |
N/A 2031-08-03 |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
12,500 | $0 | 12,500 (Direct) |
View |
2021-01-21 Option Award |
2021-01-25 5:34 pm |
N/A 2031-01-20 |
ALBIREO PHARMA INC. | ALBO | Stephenson Pamela Chief Commercial Officer |
29,200 | $0 | 51,107 (Direct) |
View |
2020-06-10 Option Award |
2020-06-11 5:36 pm |
N/A 2030-06-10 |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
15,000 | $0 | 15,000 (Direct) |
View |